Co2 Tolerance Breathing

Summary

Most people in the modern world breathe slightly too much, too fast, and through the mouth, which lowers their tolerance to carbon dioxide and biases the nervous system toward arousal; deliberately breathing less — nasal, slow, light, with comfortable (never near-water, never-while-driving) breath-holds — retrains CO₂ tolerance and is a genuinely useful adjunct for asthma and dysfunctional breathing, but its sold-as-everything "functional breathing" form rests on much thinner evidence than its marketing implies.

Why Moderate

Application A (Buteyko / breathing retraining in asthma & dysfunctional breathing) — Tier 2 (Moderate):
• because: two independent RCTs (Bruton 2018, N=655, NIHR) plus a Cochrane review (22 RCTs, ~2,880) converge on real, replicated improvements in symptoms, quality of life, and reliever use, with a coherent mechanism and an objective behavioural endpoint (medication reduction).
• NOT Tier 1 because: trials cannot be blinded, an attention/expectation component cannot be excluded, the working mechanism is not pinned (Nijmegen-null in Bruton 2018), and — tellingly — it does not change lung function, so it is a symptom/pattern adjunct, not a disease-modifying treatment.
• NOT Tier 3 because: the effect replicates across independent groups with objective medication endpoints and a textbook mechanism; this is more than "limited studies + plausibility."

Application B (CO₂-tolerance / functional breathing for general recovery, resilience, performance) — Tier 3 (Emerging):
• because: the mechanism (Bohr effect, chemoreceptor plasticity, autonomic steering) is Tier-1-solid and the practice is low-risk within the rails, so it clears "plausible mechanism + low risk."
• NOT Tier 2 because: there are essentially no adequately-controlled healthy-population RCTs isolating the CO₂/retention element from generic slow-breathing, the signature metric (BOLT) directly failed to correlate with performance (Kowalski 2024), and the supportive "evidence" is heavily commercial/testimonial.
• NOT Tier 4 because: it is mechanistically anchored in well-established physiology and shares an evidence backbone with validated slow-breathing/HRV work — it is genuinely emerging, not speculative.

(Mechanism content — Bohr effect, chemoreceptor set-point, hypocapnia/over-breathing physiology — is itself Tier-1 textbook material; the tiering above concerns the clinical/outcome claims, not the physiology.)

Practical takeaway

The whole practice is the discipline of breathing less and slower, mostly through the nose, and tolerating gentle air hunger without panic. Counter-intuitive, free, equipment-free, and — within the rails — low-risk.

Step 0 — Screen (optional, self-assessment only).
• A high Nijmegen-style symptom load (frequent sighing/yawning, unexplained breathlessness, tingling, light-headedness, chest tightness without exertion) suggests a dysfunctional/over-breathing pattern worth retraining.
• The comfortable breath-hold check (a BOLT-style self-measure, NOT a clinical test): sit, breathe normally a few minutes, then after a normal relaxed exhale pinch the nose and time until the first definite urge to breathe (not until you are struggling — that is a different, longer, riskier number). Roughly: under ~20s suggests low CO₂ tolerance / likely over-breather; 20-40s moderate; 40s+ good. Treat this as a private progress marker, never as a performance or health "score." Per the Kowalski 2024 data, it does not predict fitness.

Pillar 1 — Make nasal breathing the all-day default.
• Breathe in and out through the nose at rest, walking, sleeping, talking-permitting, and during easy exercise (the exercise-intensity nuance and crossover point are in breathing_mechanics_during_exercise).
• This alone slows breathing, adds nitric oxide, and warms/filters air. If the nose is blocked, fix that first (nasal_obstruction_and_sleep_quality) — do not force a blocked nose.

Pillar 2 — Light / reduced breathing (the core CO₂-tolerance drill).
• Sitting relaxed, nasal only. Let each breath become a little smaller and slower than your automatic breath — a soft, quiet, barely-perceptible in-breath; a relaxed, unforced out-breath. Aim toward a slow cadence (around 6 breaths/min is the well-evidenced resonance target from breath_mechanics_for_state_control).
• **The target sensation is a *light, tolerable air hunger*** — a mild "I could take a slightly bigger breath" feeling that you gently allow to persist. That mild hunger is the training stimulus (mildly elevated CO₂). It must stay comfortable. If it becomes strained, gasping, dizzy, or anxious, you have gone too far — ease off immediately.
• 3-10 minutes, once or twice a day. Stop on any light-headedness.

Pillar 3 — Comfortable breath-holds (optional, add only after pillars 1-2 are easy).
• After a normal exhale, hold gently until the first urge to breathe, then resume calm nasal breathing and let it fully settle before any repeat. Hold to the first signal, never to the limit. A handful of relaxed reps, on land, seated.
• Walking breath-holds (exhale, hold for a few comfortable steps, recover) are a common progression — same rule: first urge, never struggle, never to the point of light-headedness.

Progression.
• Weeks 1-2: nasal default + 1× light-breathing session daily. Establish the habit; learn the air-hunger edge.
• Weeks 3-8: add a second light-breathing session; introduce a few gentle seated breath-holds; carry nasal breathing into easy exercise.
• 8+ weeks: nasal breathing should feel natural at higher easy-effort intensities; the comfortable breath-hold time typically lengthens. Expect a subjective shift (calmer, less breathless, less reactive), not a spirometry or VO₂max change.

What "working" looks like / what to notice: quieter, slower resting breath; less spontaneous sighing/yawning; less easily breathless or light-headed under stress; for asthmatics, fewer reliever puffs and better day-to-day control (track this — it is the objective signal); a lengthening comfortable breath-hold. What it does NOT look like: a better VO₂max, opened airways on a lung-function test, or a guaranteed performance PR. If those are your only goals, the evidence does not promise them.

Expectation framing. Subjective breathing-comfort changes within 2-4 weeks; asthma symptom/medication benefits over 4-12 weeks in the trials. This is an adjunct and a pattern correction, not a cure and not a substitute for training, sleep, or medication.

Evidence detail

Why This Entry Exists

A Realised user reports being "a bit breathless for no reason," sighing or yawning a lot, feeling chronically wired, getting light-headed under stress, waking with a dry mouth, or simply having read about "breathing less" and wanting to know if it is real. Underneath these is a single under-recognised pattern: chronic over-breathing (chronic mild hyperventilation / "dysfunctional breathing"), where habitual breathing volume runs above metabolic need, arterial CO₂ sits low, and the body's CO₂ set-point drifts down — so the next small stressor tips the person into air hunger, light-headedness, or the somatic edge of anxiety far too easily. It is estimated to affect on the order of 6-10% of the general adult population and roughly a third of people with asthma (Nijmegen-questionnaire epidemiology). It is invisible because breathing feels automatic and "normal" by definition — you cannot notice your own baseline.

This entry exists to do two opposite jobs at once, which is exactly why it is hard to find an honest version of it anywhere else.

Job one: rescue the real thing from dismissal. "Breathing exercises" sounds like wellness fluff, and a skeptical reader (or doctor) is right to be wary. But the core clinical claim is not fluff: in asthma, structured breathing retraining (Buteyko, or physiotherapist-led breathing retraining more broadly) reliably improves symptom control, quality of life, and reduces reliever-inhaler use — and it does so without changing lung function at all. That last clause is the tell that it is real and mechanistically specific, not placebo hand-waving: it is not opening the airways, it is correcting a breathing pattern and the CO₂/hyperventilation symptoms riding on top of the disease.

Job two: rescue the reader from the over-claim. The same idea, once it left the clinic, was repackaged by commercial breathing-coach franchises (most prominently Patrick McKeown's The Oxygen Advantage) into a sweeping promise: that "functional breathing" and a high BOLT score will improve athletic performance, recovery, sleep, focus, and resilience for everyone. The honest state of that broader claim is emerging at best. The signature metric — the BOLT (Body Oxygen Level Test) breath-hold score — has been directly tested against exercise performance in elite athletes and found not associated with it at all. So Realised's job is to hand the user the genuinely useful core (retrain a dysfunctional breathing pattern; build comfortable CO₂ tolerance; default to nasal, slow, light breathing) while refusing to sell the inflated wrapper.

And it exists, above all, to carry the safety rail. This is the rare recovery practice with a documented mechanism for killing people when done wrong — breath-hold blackout in or near water. That rail is load-bearing and appears in full below.

(Two sibling entries touch the edges of this and deliberately do not cover it: breathing_mechanics_during_exercise owns nasal-vs-oral breathing during a workout and the intensity crossover; breath_mechanics_for_state_control owns acute autonomic state-shifting via breath patterns. Neither owns chronic over-breathing as a suppressor, the Buteyko-for-asthma clinical evidence, CO₂-tolerance training as a trait, or the breath-hold safety rail. This entry does.)

Evidence

Read this section as two evidence bases of very different strength, kept deliberately apart. Mixing them is the exact error the popular literature makes.
A. The strong end — breathing retraining as an adjunct in asthma & dysfunctional breathing (Tier 2, MODERATE)

Anchor RCT — independent, large, non-commercial:
Bruton, Lee, Yardley, et al. (2018), "Physiotherapy breathing retraining for asthma: a randomised controlled trial." The Lancet Respiratory Medicine 6(1):19-28. N = 655 adults with physician-diagnosed asthma, 34 UK general practices. Three arms: self-guided DVD-plus-booklet, three face-to-face physiotherapy sessions, or usual care. Funding: UK National Institute for Health Research (government/independent — no breathing-coach or device-industry money).
• Both breathing-retraining arms improved asthma-related quality of life versus usual care at 12 months: DVD+booklet adjusted mean difference 0.28 (95% CI 0.11-0.44); face-to-face 0.24 (95% CI 0.04-0.44). Both significant; the self-guided DVD was equivalent to in-person sessions (difference 0.04, CI -0.16 to 0.24) — meaning the effect is cheap and scalable.
• No significant difference in FEV₁ or exhaled nitric oxide (lung function and airway inflammation) between groups. This is the crucial, repeated finding: breathing retraining improves how the person feels and functions, not what their spirometer reads.
• No significant between-group difference in asthma attacks (9% / 11% / 15%) and, notably, no significant change on the Nijmegen questionnaire — i.e., the benefit was not cleanly explained by reduced hyperventilation symptoms, leaving the precise working mechanism partly open (the authors and a companion Lancet Resp Med correspondence debated "hypocapnia correction" as the mechanism).

The Buteyko-specific evidence and the Cochrane synthesis:
Santino, Chaves, Freitas, et al. (2020), "Breathing exercises for adults with asthma." Cochrane Database of Systematic Reviews, CD001277.pub4. 22 RCTs, ~2,880 adults with mild-to-moderate asthma (including Buteyko-method trials). Independent (Cochrane).
• Pooled finding: breathing exercises (Buteyko among them) may improve asthma symptoms, quality of life, and hyperventilation symptoms, and reduce reliever use, with little to no effect on lung function. Cochrane rated the certainty of evidence low to moderate, explicitly because of methodological limits in the underlying trials (see below).
• Multiple individual Buteyko RCTs (adults and, more recently, children aged 7-12) report large improvements in asthma-control scores and major reductions in inhaled reliever — and in some cases inhaled-steroid — dose, again without spirometry change.

Honest caveat on this body of work (the Counter-Check, applied to the proponents' own clinical claims): the trials are hampered by the thing breathing trials cannot escape — you cannot blind someone to whether they are doing breathing exercises. Reviews (e.g., Bruton & Lewith 2005, Complementary Therapies in Medicine) flag small samples, selection bias, heterogeneous protocols, and the impossibility of a true placebo. So part of the QoL benefit is plausibly attention/expectation. Cochrane's "low-to-moderate" rating already prices this in. The reason it still lands at Tier 2 rather than lower: the effect replicates across independent groups, the medication reductions are objective behavioural endpoints (not just feeling-questionnaires), and the "improves symptoms but not spirometry" dissociation is mechanistically coherent rather than the smear of a pure placebo.
B. The weak/emerging end — CO₂-tolerance & "functional breathing" for general recovery, performance, and resilience (Tier 3, EMERGING)

The signature metric is not validated against the thing it is sold on.
Kowalski, Rebis, Wilk, et al. (2024), "Body Oxygen Level Test (BOLT) is not associated with exercise performance in highly-trained individuals." Frontiers in Physiology 15:1430837. N = 49 elite speed-skaters, Wingate + cardiopulmonary exercise tests. Funding: none declared; authors declare no commercial/financial conflicts (independent).
• No significant correlation between BOLT score and any anaerobic or aerobic performance metric: r(47) ranged -0.172 to 0.013, p = 0.248 to 0.984. Authors' verbatim conclusion: "It is recommended to interpret BOLT concerning exercise performance in well-trained individuals with a great degree of caution."
• This matters because BOLT is the number the commercial functional-breathing world treats as a recovery/performance dashboard ("get your BOLT to 40s"). As a quick screen for dysfunctional breathing it has face validity (it tracks ETCO₂ and respiratory rate — see below). As a performance or recovery gauge for healthy/trained people it has, on the best direct test, none.

**The inverse CO₂-tolerance ↔ anxiety relationship is real but runs the opposite direction to a clean intervention claim.
• Across a well-replicated literature, people with panic disorder and related anxiety phenotypes show CO₂ hypersensitivity** — a "false suffocation alarm," exaggerated panic/ventilatory response to inhaled CO₂ (e.g., Klein's suffocation-alarm model; multiple 35%-CO₂-challenge studies). Low CO₂ tolerance and anxiety genuinely travel together.
• BUT this is mostly observational / trait evidence (CO₂ sensitivity as an endophenotype), not evidence that deliberately training CO₂ tolerance in non-clinical people lowers their anxiety. The arrow "low CO₂ tolerance → anxiety" is documented; the arrow "CO₂-tolerance training → durably less anxiety in healthy people" is the inference proponents make and is not yet established by RCTs. (And the same CO₂-sensitivity literature is precisely why panic disorder is a contraindication to aggressive breath-hold work — see Risks.)

The dysfunctional-breathing screening tool is sound (this is the bridge between A and B).
• The Nijmegen Questionnaire (16 somatic items; score >23/64 flags hyperventilation syndrome) was validated at ~91% sensitivity / 95% specificity and its total score correlates with end-tidal CO₂ (r ≈ -0.68), respiratory rate (r ≈ +0.66), and breath-hold time (r ≈ -0.65). This is the empirical backbone for "chronic over-breathing is a measurable pattern, and breath-hold tolerance indexes it." It legitimises screening and retraining a dysfunctional pattern. It does not legitimise breath-hold scores as a fitness/recovery KPI for already-normal breathers.

General breathwork-for-stress signal (adjacent, supportive, not specific): broader slow-breathing and breathwork RCT evidence (covered in breath_mechanics_for_state_control) shows reliable acute HRV/vagal and mood effects. Where breath-retention breathwork has been tested head-to-head against a good active comparator in healthy young adults, it has not clearly beaten it — i.e., much of the benefit is shared with any structured slow-breathing practice, not unique to the CO₂/retention element.

Mechanism

Three linked physiological facts, all Tier-1-solid, explain why "breathe less" is even coherent advice. The mechanism is far stronger than the clinical trials — which, on a topic this commercially under-resourced for healthy-population studies, is itself informative.

1. The Bohr effect — CO₂ is not just waste; it is the key that unloads oxygen. Haemoglobin releases O₂ to tissues more readily when local CO₂/acidity is higher. So chronically blowing off CO₂ by over-breathing is self-defeating: it raises blood O₂ saturation (which feels like "more oxygen") while making haemoglobin cling to that oxygen and deliver less of it to muscle and brain, and it constricts cerebral vessels. The counter-intuitive core: at rest you are not short of oxygen; loading more air does not help, and may hinder delivery. Tolerating a little more CO₂ improves the unloading.

2. Chemoreceptor set-point / CO₂ tolerance is trainable. Central and peripheral chemoreceptors trigger the urge to breathe when arterial CO₂ (PaCO₂) rises to roughly 45-60 mmHg. Chronic over-breathing keeps baseline CO₂ low and the receptors "twitchy," so the breathe-urge fires early and hard — low tolerance, easy air hunger, easy hyperventilatory spiral. Repeated, comfortable exposure to mildly elevated CO₂ (light breathing; gentle breath-holds to the first air hunger, not to struggle) gradually shifts tolerance so the system stops over-reacting. This is the same adaptation breathing_mechanics_during_exercise documents in nasal-trained runners (Dallam 2018: higher CO₂ tolerance, better ventilatory efficiency).

3. Breathing is the steering wheel of the autonomic nervous system. Slow, nasal, diaphragmatic breathing raises vagal tone and HRV and biases toward parasympathetic recovery; fast, shallow, mouth breathing biases toward sympathetic arousal (the full autonomic mechanism is in breath_mechanics_for_state_control). Chronic over-breathing therefore isn't just a gas problem — it is a low-grade, all-day sympathetic lean. Nasal breathing additionally generates nitric oxide (a vasodilator that improves perfusion) and humidifies/filters air.

Why "modern suppressor"? Sedentary mouth-breathing, chronic low-grade stress (which drives faster breathing), talking all day, processed high-acid-load diets, and nasal congestion all nudge habitual ventilation upward and tolerance downward. Nothing in modern life nudges it back. The intervention is corrective — returning breathing toward its quiet, nasal, metabolically-matched baseline — which is squarely Realised's recovery, not optimisation register: you are not boosting breathing, you are removing a chronic over-drive.

The honest limit of the mechanism: a beautiful mechanism is necessary but not sufficient. The Bohr effect and chemoreceptor plasticity are textbook; they explain why the asthma/dysfunctional-breathing results are real. They do not by themselves prove that a healthy person who trains CO₂ tolerance gets meaningfully better recovery, sleep, or performance — that leap is where the evidence thins and the marketing thickens.

Risks And Contraindications

This is the part that is genuinely load-bearing. Light, slow, nasal breathing at rest is about as low-risk as an intervention gets. The risk lives entirely in the breath-hold / reduced-breathing component, because deliberately suppressing the urge to breathe can drive hypocapnia (low CO₂) and hypoxia (low O₂), and the two together remove the body's warning system.

THE BREATH-HOLD RAIL — non-negotiable:
• NEVER perform breath-holds, breath retention, or reduced-breathing drills in, on, or near water. Ever. This is the documented killer. Mechanism (StatPearls, "Shallow Water Blackout"; freediving-blackout literature): hyperventilating or even just holding the breath lowers PaCO₂, which delays the urge to breathe; the swimmer/diver then stays under while oxygen falls, and "arterial oxygen levels drop rapidly at the tail end of the oxygen curve," producing sudden loss of consciousness with no warning and no struggle — and then drowning. Shallow-water/hypoxic blackout is a leading mechanism in breath-hold drownings, falls disproportionately on young males, and "hyperventilation does not meaningfully increase safe dive time" — it only removes the alarm. No breath-hold training in a pool, bath, lake, or sea, and not poolside.
• NEVER perform breath-holds or hyperventilatory/retention breathwork while driving or operating machinery, or anywhere a brief faint would cause harm (standing at height, on stairs, cooking at a hot stove). Light-headedness and syncope are foreseeable.
• **Always practise seated or lying down, on dry land. Hold to the first urge to breathe, never to the limit. Stop instantly on dizziness, tingling, visual changes, or rising anxiety.

Population contraindications — do not use the breath-hold / strong reduced-breathing component (gentle all-day nasal breathing is generally fine) without medical clearance if you have:
• Pregnancy — avoid breath-holds and hypoxic/hypercapnic drills (foetal oxygenation; not studied as safe).
• Cardiovascular disease — uncontrolled hypertension, arrhythmia, ischaemic heart disease, history of stroke/TIA (breath-holds and Valsalva-like efforts spike blood pressure and stress the heart).
• Respiratory disease — and specifically, see the clinical rail below for asthma.
• Epilepsy / seizure disorders — hypocapnia and hypoxia can lower seizure threshold.
• Panic disorder / severe anxiety** — air hunger and the CO₂/hypocapnia shifts can trigger panic; the CO₂-hypersensitivity (false-suffocation-alarm) literature is exactly why. Some people benefit from very gentle slow breathing, but aggressive breath-holds and intense reduced-breathing can backfire badly. Proceed only slowly, ideally with guidance.
• Type 1 diabetes — caution; autonomic and counter-regulatory responses can be altered, and the stress of intense breath-holds is poorly characterised in this group.

THE CLINICAL RAIL (asthma): Buteyko and breathing retraining are adjuncts, not replacements. They reduce reliever use because symptoms improve — but a user must never reduce or stop prescribed asthma medication (especially inhaled corticosteroid "preventer" therapy) on their own on the strength of feeling better. Reliever reduction should be doctor-supervised; preventer therapy should not be self-tapered. The trials reduced medication within supervised studies; the airway disease itself is unchanged (lung function did not improve). Always keep a rescue inhaler available and do not force nasal-only or reduced breathing during an asthma exacerbation.

General: stop and reassess if reduced-breathing practice consistently produces light-headedness, anxiety, headaches, or palpitations rather than calm — that is the wrong dose or the wrong tool for you.

Controversy

Nature: Practical / commercially-influenced over-claim — not a genuine scientific dispute about the underlying physiology, but a gap between a narrow honest finding and a broad marketed promise.

**Position A — Functional-breathing proponents (Patrick McKeown / The Oxygen Advantage, Buteyko-coach franchises; commercial: books, certifications, apps, paid courses).
• Claim: modern humans chronically over-breathe; raising CO₂ tolerance (tracked by BOLT) improves athletic performance, recovery, sleep, focus, and stress resilience for nearly everyone.
• Best evidence: the genuine Bohr-effect / chemoreceptor mechanism; the real asthma/dysfunctional-breathing clinical results; the nasal-breathing adaptation literature; large volumes of practitioner testimony.
• Limitation: extrapolates a clinical-population, symptom-pattern finding to healthy-population performance/recovery without the RCTs to support it; leans on BOLT as a performance/recovery KPI that has been directly tested and failed to correlate with performance (Kowalski 2024); strong financial incentive to maximise the claim.

Position B — Sports-science / respiratory-medicine mainstream.**
• Claim: breathing retraining is a legitimate adjunct for asthma and dysfunctional breathing (improves QoL and symptoms, not lung function); for healthy, already-normal breathers the performance/recovery case is unproven, and BOLT is not a validated performance metric.
• Best evidence: Cochrane CD001277; Bruton 2018 (independent, NIHR-funded); Kowalski 2024 (independent BOLT null).
• Limitation: can under-rate the real, lived improvement many over-breathers report, and the difficulty of funding healthy-population breathing RCTs means "no evidence" here partly reflects no funding to look, not a tested negative.

**The funding/bias dimension (and why it points the opposite way to most Realised entries): the usual Realised pattern is industry suppressing a cheap, unpatentable intervention. Here the distortion runs the other way — the cheap unpatentable practice has a vocal commercial proponent layer** (coach certifications, branded methods, apps) whose incentive is to over-state breadth and to elevate a memorable metric (BOLT) into a dashboard. The most-cited dismissive and the most-cited supportive clinical studies (Kowalski 2024; Bruton 2018; Cochrane) are all independent/government-funded — so the cleanest evidence is the non-conflicted evidence, and it lands in the honest middle: real for asthma/dysfunctional breathing, unproven-but-plausible for general recovery, and not validated for performance via BOLT.

Realised Position: Chronic over-breathing is a real, measurable, under-recognised pattern, and retraining it — nasal default, light slow breathing, comfortable breath-holds — is a legitimate, low-cost recovery act with solid mechanism and moderate clinical evidence in asthma and dysfunctional breathing. For a healthy user it is a reasonable, pleasant, plausibly-beneficial practice that aligns with everything we know about slow breathing and autonomic recovery — offered as emerging, framed as pattern-correction and calm, not sold as a performance, VO₂max, longevity, or guaranteed-recovery upgrade, and not measured by treating BOLT as a KPI. The breath-hold rail is absolute. See What Would Change Our Mind.

Cross-Pillar Connections

• Physical — breathing_mechanics_during_exercise: the during-workout counterpart. CO₂ tolerance trained at rest (this entry) is the same adaptation that lets a trained nasal breather hold nasal breathing to higher submaximal intensities (Dallam 2018). That entry owns the intensity crossover and the "breathe however you can at max effort" rule; this entry owns the resting-pattern correction.
• Mental — breath_mechanics_for_state_control: the acute autonomic counterpart. Slow, exhale-emphasised, nasal breathing is the shared substrate; that entry covers minutes-scale state-shifting (cyclic sighing, box, resonance breathing), this entry covers the trait-scale CO₂ set-point and the chronic-over-breathing pattern beneath it. Note that entry's own caution: hyperventilatory/retention protocols carry the same near-water / driving / panic / pregnancy rails.
• Mental — autonomic_nervous_system_balance: chronic over-breathing is, functionally, an all-day low-grade sympathetic lean; correcting it is a parasympathetic-recovery act in Realised's restore, not optimise register.
• Sleep — nasal_obstruction_and_sleep_quality: nasal breathing is the gateway to this whole practice; a blocked nose is an upstream blocker to fix first, and daytime mouth-breathing habits reinforce night-time mouth breathing.
• Diet (minor): high acid-load and over-eating can nudge ventilation; adequate hydration supports nasal mucosa. No strong direct interaction.

What would change our mind

Industry bias note

Sources (18)

• *Asthma / dysfunctional-breathing clinical (Application A):**↗
• Bruton A, Lee A, Yardley L, et al. Physiotherapy breathing retraining for asthma: a randomised controlled trial. The Lancet Respiratory Medicine. 2018;6(1):19-28. (N=655; NIHR/government-funded; independent.)↗
• Santino TA, Chaves GSS, Freitas DA, et al. Breathing exercises for adults with asthma. Cochrane Database of Systematic Reviews. 2020;CD001277.pub4. (22 RCTs, ~2,880 adults; Cochrane/independent; certainty low-to-moderate.)↗
• Bruton A, Lewith GT. The Buteyko breathing technique for asthma: a review. Complementary Therapies in Medicine. 2005;13(1):41-46. (Independent review; methodological-limits critique.)↗
• Recent paediatric Buteyko RCT (children 7-12, asthma control & QoL improved with large effect sizes; spirometry unchanged) — PMC12143287.↗
• (Companion debate) Hypocapnia correction as a working mechanism for breathing retraining in asthma — correspondence, The Lancet Respiratory Medicine, 2018.↗
• *BOLT / functional-breathing metric (Application B):**↗
• Kowalski T, Rebis K, Wilk A, et al. Body Oxygen Level Test (BOLT) is not associated with exercise performance in highly-trained individuals. Frontiers in Physiology. 2024;15:1430837. (N=49 elite speed-skaters; no funding, no conflicts; independent. r(47) = -0.172 to 0.013, p = 0.248-0.984.)↗
• *Dysfunctional breathing / hyperventilation epidemiology & screening:**↗
• van Dixhoorn J, Folgering H. The Nijmegen Questionnaire and dysfunctional breathing. ERJ Open Research. 2015;1(1):00001-2015. (NQ validity ~91% sens / 95% spec; correlations with ETCO₂ r≈-0.68, RR r≈+0.66, breath-hold time r≈-0.65; HVS prevalence ~6-10%.)↗
• Dysfunctional breathing review & classification — PMC9487208.↗
• *CO₂ sensitivity ↔ anxiety (mechanism + contraindication basis):**↗
• Klein DF. False suffocation alarm model and the 35%-CO₂-challenge literature in panic / separation anxiety disorder (multiple studies; CO₂ hypersensitivity as a trait endophenotype). (Observational/challenge studies; basis for panic-disorder caution.)↗
• *Safety — breath-hold blackout:**↗
• Shallow Water Blackout. StatPearls, NCBI Bookshelf, NBK554620. (Hyperventilation lowers PaCO₂ and delays the urge to breathe; O₂ falls at the tail of the curve; sudden LoC without warning; leading mechanism in breath-hold drownings; disproportionately young males.)↗
• Freediving-blackout / shallow-water-blackout safety literature (RLSS UK guidance GS005; underwater hypoxic blackout resources).↗
• *Adjacent breathwork mechanism/evidence (cross-referenced, not re-argued here):** Laborde et al. 2022 (slow breathing & HRV meta-analysis, 223 studies); Balban/Huberman et al. 2023 (Cell Reports Medicine, breathwork RCT) — see breath_mechanics_for_state_control.↗
• Funding notation: the three pivotal clinical/metric studies (Cochrane CD001277, Bruton 2018, Kowalski 2024) are independent or government-funded with no commercial conflicts. The principal source of the broad "functional breathing for everyone" claim is commercial (branded methods, certifications, books, apps) — weight accordingly.*↗

Related entries